Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells

Leukemia. 2015 Jul;29(7):1605-8. doi: 10.1038/leu.2015.16. Epub 2015 Feb 2.

Authors

A Pardanani¹, T Lasho¹, D Chen², T K Kimlinger¹, C Finke¹, D Zblewski¹, M M Patnaik¹, K K Reichard², E Rowinsky³, C A Hanson², C Brooks³, A Tefferi¹

Affiliations

¹ Division of Hematology and Department of Medicine, Rochester, MN, USA.
² Division of Hematopathology and Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
³ Stemline Therapeutics Inc., New York, NY, USA.

PMID: 25640886
DOI: 10.1038/leu.2015.16

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Bone Marrow / metabolism
Bone Marrow / pathology*
Flow Cytometry
Humans
Immunoenzyme Techniques
Immunophenotyping
Interleukin-3 Receptor alpha Subunit / metabolism*
Mast Cells / metabolism
Mast Cells / pathology*
Mastocytosis, Systemic / metabolism
Mastocytosis, Systemic / pathology*
Tumor Cells, Cultured

Substances

IL3RA protein, human
Interleukin-3 Receptor alpha Subunit